Hilary Allen on why we shouldn’t subsidize fintech, Amy Kapczynski on what it will take to make public pharma work, and Maryam Jamshidi on the economic considerations at the heart of recent U.S. Sanctions. Plus, two cool CfPs (including one conference near and dear to our heart), a fellowship down under, an event on the post-Dobbs landscape, and. . .